Southeast Asia Medical Device Regulatory Access · One-stop Consulting
Indonesia / Vietnam / Malaysia / Philippines / Thailand / SingaporeMedical Device Registration
Direct delivery by local teams and joint ventures in all six markets — from product classification, dossier submission and approval to post-market compliance — an efficient, predictable and stable SEA market-access solution.
Spanning imaging, monitoring, orthopaedic implants, dental, ophthalmology, AI software and more
0+
Local Experts
Local teams & joint ventures in six markets, native-level liaison
0%
Faster Approval Cycles
About 40% faster than typical market timelines
0
Registration Cases
90%+ are medical devices, verifiable in official databases
Why ZANFORA
Local Entities · Predictable Delivery
We maintain local teams, resident staff and joint ventures in all six Southeast Asian markets, with registrations held by the manufacturer — helping you keep control of your market position.
🏢
Direct Presence in 6 Markets
Local teams, resident staff and joint ventures manage the entire registration process. Registrations are held by the manufacturer — no distributor lock-in.
⚡
Review-risk Anticipation
We know the deficiency-letter habits of BPOM, MOH, MDA, PFDA, TFDA and HSA, reducing review rounds and cutting approval time by about 40% versus market averages.
🤝
Zero Time-zone, Native-language Liaison
Our China team connects directly with local experts in six markets: Chinese-language project management, local delivery, zero language barrier, zero time difference, real-time updates at key milestones.
🧭
NMPA-plus-SEA Portfolio Strategy
Use your NMPA registration as the reference-country approval to chain market access across six SEA markets, reusing ASEAN CSDT dossiers with multi-market submissions to Malaysia, Thailand and Singapore.
Services
A Two-dimensional Service Matrix
Browse each market's requirements and latest regulatory updates by country, or explore by service line.
Indonesia
Ministry of Health (Kemenkes) / BPOM
With 280 million people, Indonesia is ASEAN's largest single market. Medical devices and IVD are registered with the Ministry of Health (Kemenkes) under risk classes A–D; BPOM handles certain disinfectant/combination products; and from 2026, halal certification is being phased in for devices containing animal-derived materials.
Ministry of Health (MOH) — Department of Medical Equipment (DME)
Vietnam uses an A–D classification with 5-year registration validity. Registration fees are being cut by 50% in phases in 2026, and Decree 37/2026 updates labelling requirements. The Class A/B self-declaration route is extremely fast, making Vietnam a classic quick-turnaround market.
Malaysia regulates under Act 737; Class B/C/D registrations require CAB conformity assessment. Full registration mutual recognition is in place with Thailand's TFDA and Singapore's HSA — reference-country approvals unlock verification routes, making Malaysia the core hub for multi-market ASEAN submissions.
The Philippines manages devices under RA 9711 and AO 2018-0002 (aligned with the AMDD) via CMDN/CMDR, with registration fees currently suspended in phases. Foreign manufacturers must appoint a Local Authorized Representative (LAR) and rely on LTO-licensed importers for distribution.
Thailand applies the AMDD four-class system with three routes: Class A Notification, Class B Listing and Class C/D Registration. The 2026 electronic change system is live and Malaysia mutual recognition is fully in force — overall access certainty is high.
Singapore is ASEAN's most mature and international regulatory hub market. HSA manages Classes A–D and offers Immediate/Abridged/Full/Expedited evaluation routes based on reference-country approvals; registrations remain valid long term with annual renewal.
Clarify the key questions before your access assessment
General regulatory information only. The applicable pathway depends on your product and current local requirements.
Which products can start with a Southeast Asia access assessment?
Active and non-active medical devices, IVDs and SaMD can be assessed. Provide intended use, technical features, existing certificates and target markets so classification, pathway and documentation gaps can be reviewed.
Can I apply without NMPA, CE or FDA approval?
It depends on the target market, device class and reference-country requirements. Some pathways require prior approval while others accept a complete technical submission. Current local rules and authority guidance always prevail.
How are registration ownership and local representation handled?
The plan is designed to protect the manufacturer's registration interests. Certificate holding, authorised representation and importer arrangements are confirmed in writing before submission to reduce later change-of-holder risks.
How can multi-market submissions reduce duplicated work?
A CSDT-based dossier can support reuse, alongside reference approvals, local classification and labelling requirements. Reusable content must be checked market by market; reuse does not automatically mean mutual recognition.
Contact Us
Start Your SEA Market Access Journey
A senior consultant will contact you within 1 business day with a free initial access assessment.